EP Patent

EP3777862A1 — Meloxicam composition, preparation and preparation method and use thereof

Assigned to Nanjing Delova Biotech Co Ltd · Expires 2021-02-17 · 5y expired

What this patent protects

The invention provides a meloxicam compositions, pharmaceutical preparations, preparation methods and use thereof. In one aspect of the invention, meloxicam compositions containing meloxicam and cosolvents are provided, wherein the cosolvents are mixed solvents including water an…

USPTO Abstract

The invention provides a meloxicam compositions, pharmaceutical preparations, preparation methods and use thereof. In one aspect of the invention, meloxicam compositions containing meloxicam and cosolvents are provided, wherein the cosolvents are mixed solvents including water and organic solvents. In another aspect of the invention, other compositions comprising meloxicam, solvents, and pH regulators are provided, wherein the pH regulators include at least citric acid. The pharmaceutical compositions of the invention can significantly enhance the solubility of meloxicam in liquid pharmaceutical preparations, as well as excellent stability. The meloxicam compositions provided in the invention can even be directly used for intravenous injection administration to quickly reach effective therapeutic concentrations for post-operative analgesia. Furthermore, the preparation technique of the compositions is convenient that it can be completed by stirring and dispersing in a short time at room temperature, and the large-scale production is easy to be achieved.

Drugs covered by this patent

Patent Metadata

Patent number
EP3777862A1
Jurisdiction
EP
Classification
Expires
2021-02-17
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Delova Biotech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.